MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents, including...
$66,549K
Inventories
$24,016K
Trade receivables,
net of allowances of...
$13,068K
Prepaid expenses and
other assets
$1,488K
Total current assets
$105,121K
Intangible assets, net
$5,485K
Right-of-use assets, net
$2,019K
Leasehold improvements
and equipment, net
$1,298K
Other long-term
assets
$406K
Total assets
$114,329K
Total liabilities and
stockholders' equity
$114,329K
Total stockholders'
equity
$82,330K
Total liabilities
$31,999K
Accumulated deficit
-$158,210K
Cumulative translation
adjustments
-$3K
Additional paid-in capital
$240,464K
Total current
liabilities
$22,824K
Deferred consideration
liability, less current...
$5,059K
Deferred revenue
$2,572K
Operating lease
obligations, less current...
$1,544K
Common stock, 0.001 par
value authorized...
$79K
Accounts payable
$13,277K
Accrued expenses
$7,621K
Current maturities of
operating lease...
$1,032K
Current deferred
consideration liability
$514K
Customer deposits
$380K
Back
Back
Balance Sheet
source: myfinsight.com
Niagen Bioscience, Inc. (NAGE)
Niagen Bioscience, Inc. (NAGE)